To better evaluate the clinical impact of LSM1 expression, we next tested its effect on overall survival (Figure 3(a)), disease-specific survival (Figure 3(b)), and progression-free survival (Figure 3(c)) in glioma patients. This evidence concerns the gene LSM1 and central nervous system cancer.